These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 12766782)

  • 1. Asthma morbidity, control and treatment in New Zealand: results of the Patient Outcomes Management Survey (POMS), 2001.
    Holt S; Kljakovic M; Reid J;
    N Z Med J; 2003 May; 116(1174):U436. PubMed ID: 12766782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of asthma action plans to childhood asthma: national survey repeated.
    McNally AJ; Frampton C; Garrett J; Pattemore P
    N Z Med J; 2004 Jun; 117(1196):U932. PubMed ID: 15280936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Survey on changes in asthma treatment and management].
    Raimondi GA; Sívori M
    Medicina (B Aires); 2004; 64(3):201-12. PubMed ID: 15239533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asthma in New Zealand--time to get control.
    Beasley R; Masoli M
    N Z Med J; 2003 May; 116(1174):U434. PubMed ID: 12766780
    [No Abstract]   [Full Text] [Related]  

  • 5. Wheezing in Chinese schoolchildren: disease severity distribution and management practices, a community-based study in Hong Kong and Guangzhou.
    Ko FW; Wang HY; Wong GW; Leung TF; Hui DS; Chan DP; Zhong NS; Lai CK
    Clin Exp Allergy; 2005 Nov; 35(11):1449-56. PubMed ID: 16297141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asthma control in Switzerland: a general practitioner based survey.
    Leuppi JD; Steurer-Stey C; Peter M; Chhajed PN; Wildhaber JH; Spertini F
    Curr Med Res Opin; 2006 Nov; 22(11):2159-66. PubMed ID: 17076976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
    Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter survey of childhood asthma in Turkey. II: Utilization of asthma drugs, control levels and their determinants.
    Soyer OU; Beyhun NE; Demir E; Yildirim S; Boz AB; Altinel N; Cevit O; Karakaş T; Anlar Y; Söğüt A; Altintaş D; Canitez Y; Büyükdereli Z; Sekerel BE
    Pediatr Allergy Immunol; 2009 Mar; 20(2):172-9. PubMed ID: 18823358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of inhalation therapy in bronchial asthma in adults above twelve years of age in armed forces.
    Barthwal MS; Deoskar RB; Rajan KE
    J Assoc Physicians India; 2005 Aug; 53():681-4. PubMed ID: 16398075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS; Yawn BP
    Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in asthma insights and reality in Japan (AIRJ) in 2005 since 2000].
    Adachi M; Ohta K; Morikawa A; Nishima S; Tokunaga S; Disantostefano RL
    Arerugi; 2008 Feb; 57(2):107-20. PubMed ID: 18349585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Asthma Insights & Reality in Japan 2005].
    Adachi M; Ohta K; Morikawa A; Nishima S
    Arerugi; 2006 Oct; 55(10):1340-3. PubMed ID: 17072115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor asthma control in children: evidence from epidemiological surveys and implications for clinical practice.
    Gustafsson PM; Watson L; Davis KJ; Rabe KF
    Int J Clin Pract; 2006 Mar; 60(3):321-34. PubMed ID: 16494648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical survey to understand real asthma life for patients-I].
    Ohta K; Minoguchi K; Kii K
    Arerugi; 2010 Jun; 59(6):676-87. PubMed ID: 20574144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asthma insights and reality in Turkey (AIRET) study.
    Sekerel BE; Gemicioglu B; Soriano JB
    Respir Med; 2006 Oct; 100(10):1850-4. PubMed ID: 16564685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of clinical practices in asthma].
    Gaga M
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S31-10S33. PubMed ID: 17127959
    [No Abstract]   [Full Text] [Related]  

  • 19. Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire.
    Juniper EF; Bousquet J; Abetz L; Bateman ED;
    Respir Med; 2006 Apr; 100(4):616-21. PubMed ID: 16226443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Asthma control level in asthmatic children followed in general practice medicine in France: results of ER'ASTHME study].
    de Blic J; Boucot I; Pribil C; Huas D; Godard P
    Arch Pediatr; 2007 Sep; 14(9):1069-75. PubMed ID: 17566720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.